4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001562180-16-001980
CIK 0001369786operating
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 2:08 PM ET
Size
7.0 KB
Accession
0001562180-16-001980
Insider Transaction Report
Form 4
Harmon J Frank
EVP, Global Operations
Transactions
- Award
Common Stock
2016-03-14+8,915→ 8,915 total - Award
Stock Option to Buy
2016-03-14+18,897→ 18,897 totalExercise: $13.46Exp: 2026-03-14→ Common Stock (18,897 underlying)
Footnotes (1)
- [F1]The option vests in four equal installments beginning on March 14, 2017.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 2:08 PM ET
- Size
- 7.0 KB